ArticleTherapeutic advances in medical oncology2025
The characteristics of HER2-positive microinvasive breast cancer and the necessity of systemic adjuvant therapy in these patients: a multicenter real-world study.
Bo Lan et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.